Technical Analysis for PODD - Insulet Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Crossed Above 200 DMA | Bullish | 1.02% | |
| New Uptrend | Bullish | 1.02% | |
| Above Upper BB | Strength | 1.02% | |
| Up 3 Days in a Row | Strength | 1.02% |
| Alert | Time |
|---|---|
| Up 1% | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Down 1% | 1 day ago |
| Fell Below Upper Bollinger Band | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/09/2024
Insulet Corporation Description
Insulet Corporation, a medical device company, engages in the development, manufacture, and sale of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Pharmaceutical Diabetes Medical Equipment Telehealth Telemedicine Glucose Insulin Endocrine System Diabetes Mellitus Endocrinology Durable Medical Equipment Treatment Of Diabetes Diabetes Management Infusion Systems Insulin Dependent Diabetes Insulin Pump
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 309.72 |
| 52 Week Low | 125.82 |
| Average Volume | 874,171 |
| 200-Day Moving Average | 180.50 |
| 50-Day Moving Average | 171.36 |
| 20-Day Moving Average | 172.79 |
| 10-Day Moving Average | 176.62 |
| Average True Range | 7.83 |
| RSI (14) | 61.39 |
| ADX | 28.82 |
| +DI | 35.66 |
| -DI | 9.33 |
| Chandelier Exit (Long, 3 ATRs) | 169.80 |
| Chandelier Exit (Short, 3 ATRs) | 183.69 |
| Upper Bollinger Bands | 187.32 |
| Lower Bollinger Band | 158.26 |
| Percent B (%b) | 1.0 |
| BandWidth | 16.82 |
| MACD Line | 2.60 |
| MACD Signal Line | 1.07 |
| MACD Histogram | 1.5294 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 194.57 | ||||
| Resistance 3 (R3) | 193.89 | 190.78 | 193.35 | ||
| Resistance 2 (R2) | 190.78 | 188.92 | 191.12 | 192.95 | |
| Resistance 1 (R1) | 189.02 | 187.77 | 189.90 | 189.70 | 192.54 |
| Pivot Point | 185.91 | 185.91 | 186.35 | 186.25 | 185.91 |
| Support 1 (S1) | 184.16 | 184.05 | 185.04 | 184.84 | 182.00 |
| Support 2 (S2) | 181.05 | 182.91 | 181.39 | 181.59 | |
| Support 3 (S3) | 179.29 | 181.05 | 181.19 | ||
| Support 4 (S4) | 179.97 |
